DEA Archived Press Releases

Press Releases before January 20, 2025
897 Results - Showing 1 to 10
PRESS RELEASE

DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients

WASHINGTON – The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established during the COVID-19 public health emergency while also establishing new patient protections. In developing these rules, DEA has focused on the patient to ensure telemedicine is accessible for medical care...
PRESS RELEASE

Antelope Valley Man Faces New Charge Alleging He Knowingly Sold Fentanyl to Second Victim Who Died

LOS ANGELES – A Palmdale man already facing one charge of distribution of fentanyl resulting in death has been charged by federal grand jury indictment with an additional count of distribution of fentanyl resulting in death related to the death of a Palmdale man in August, the Justice Department announced...
PRESS RELEASE

DEA’s OD Justice Devotes Critical Resources to Fatal Drug Poisoning and Overdose Death Investigations Across the United States

WASHINGTON – Operation OD Justice is a DEA initiative born out of a critical need to investigate drug poisoning and overdose deaths across the U.S. The initiative, launched in 2021 by DEA’s Los Angeles and San Diego Field Divisions, offers training, resources, and poisoning response coordinators to assist State and...
PRESS RELEASE

Drug Trafficker and Money Launderer Sentenced to 15 Years in Prison

PHOENIX, Ariz. – Yvette Porras-Ochoa, 42, of Wittmann, was sentenced last week by United States District Judge Steven P. Logan to 180 months in prison. Porras-Ochoa pleaded guilty to Conspiracy to Possess with Intent to Distribute 50 grams or more of Cocaine, Conspiracy to Possess with Intent to Distribute Prescription...
PRESS RELEASE

Head of Drug Trafficking Organization Sentenced to 14 Years in Prison

PHOENIX, Ariz. – Heriberto Lopez-Landeros, 44, of Avondale, was sentenced last week by United States District Judge Steven P. Logan to 14 years in prison. Lopez-Landeros pleaded guilty to Possession with Intent to Distribute Methamphetamine on August 5, 2024. Lopez-Landeros was the head of an Arizona-based drug trafficking organization responsible...
PRESS RELEASE

Santa Clarita Man Charged with Distributing Opioid More Powerful than Fentanyl and Causing Victim’s Overdose Death

LOS ANGELES – A Santa Clarita man has been arraigned on an indictment alleging he distributed protonitazene – a novel synthetic opioid that is up to three times more powerful than fentanyl – which resulted in a victim’s fatal overdose this spring, the Justice Department announced today. Benjamin Anthony Collins...
PRESS RELEASE

Tenth Bilateral Drug Intelligence Working Group in Shanghai, China

From November 12-13, 2024, the U.S. Department of Justice, led by the Drug Enforcement Administration (DEA), along with U.S. Customs and Border Protection (CBP) participated in the tenth Bilateral Drug Intelligence Working Group in Shanghai, China. DOJ, DEA, and CBP officials met with law enforcement counterparts from China’s Ministry of...
PRESS RELEASE

DEA’s Third Annual National Family Summit on Fentanyl Highlights Progress in Fight to Save Lives

WASHINGTON – The U.S. Drug Enforcement Administration hosted the third annual National Family Summit on Fentanyl on November 14 and 15. For the past three years, DEA has invited families who have lost a loved one to a fentanyl drug poisoning or overdose to gather in the nation’s capital and...
PRESS RELEASE

Arizona Communities Turn In 5,367 Pounds of Unneeded Medications on DEA’s National Prescription Drug Take Back Day

Phoenix, Ariz. – DEA and local law enforcement partners collected 5,367 pounds of unneeded medications in Arizona during the 26th National Take Back Day on October 26, 2024. Nationwide, 630,000 pounds of unneeded medications were turned in at 4,600 locations. Since its inception, DEA’s National Prescription Take Back Day has...
PRESS RELEASE

China-Based Chemical Company, Its Director and Senior Employees Indicted for Alleged Fentanyl Manufacturing and Distribution

LOS ANGELES – A chemical company, its director and three senior employees have been charged in a 13-count federal grand jury indictment alleging they sold deadly fentanyl precursor chemicals and xylazine – known as “tranq” – globally, fueling the fentanyl crisis in the United States, the Justice Department announced today...